Boston Scientific
As on 02 Jul, 2025 | 01:29 IST
| Open | 107.17 |
| Previous Close | 107.41 |
| Beta | 0.37 |
| High | 107.40 |
| Low | 103.98 |
| TTM EPS See historical trend | 2.70(+26.17% YoY) |
| 52 Week High | 107.53 |
| 52 Week Low | 72.01 |
| TTM PE See historical trend | 38.80(High PE) |
| Mkt. Cap ($ Billion) | 154.38 |
| Dividend Yield | -- |
Advanced Chart
*Delayed by 20 seconds
MC Technicals
| Days | |
|---|---|
| 5 | 105.61 |
| 10 | 103.9 |
| 20 | 102.37 |
| 50 | 102.89 |
| 100 | 101.65 |
| 200 | 95.49 |
Returns
| 1 Week | 2.33% | |
| 1 Month | -0.44% | |
| 3 Months | 5.49% | |
| YTD | 17.37% | |
| 1 Year | 36.00% | |
| 3 Years | 181.06% |
Financialsin million $
Peers
| Name | Price ($) | Change% | M.Cap(Billion $) | TTM PE | TTM EPS | DY | 52 wk high/low | Technical Rating | |
|---|---|---|---|---|---|---|---|---|---|
| J&J | 177.18 | -0.49 | 426.52 | 16.89 | 10.49 | 2.88 | 178.99/0.00 | 13.43 | Neutral |
| Abbott | 131.38 | -0.06 | 227.99 | 30.70 | 4.28 | 1.87 | 131.66/0.00 | 0.58 | Bearish |
| Intuitive Surgical | 473.86 | 0.58 | 166.83 | 88.74 | 5.34 | -- | 475.60/0.00 | -20.52 | Neutral |
| Boston Scientific | 105.70 | -0.16 | 154.85 | 53.12 | 1.99 | -- | 107.00/0.00 | -0.47 | Bearish |
| Danaher | 205.36 | 0.18 | 151.75 | 22.08 | 9.30 | 0.45 | 207.39/0.00 | -0.63 | Bearish |
Market news
- Stocks finish week higher; Wall Street at record highsSeptember 20, 2025 7:43 AM
- Nasdaq notches record high close, traders look to Fed meetingSeptember 13, 2025 9:16 AM
- Wall Street indexes end lower as jobs data fuels economic worriesSeptember 6, 2025 10:13 AM
- S&P 500 ends lower as Dell and Nvidia dropAugust 30, 2025 10:46 AM
About the company
Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company offers its products by businesses such Interventional Cardiology, Peripheral Interventions, Cardiac Rhythm Management, Electrophysiology, Endoscopy, Urology and Pelvic Health, Neuromodulation and Specialty Pharmaceuticals. It operates in three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. MedSurg consists of Endoscopy and Urology and Pelvic Health businesses. Rhythm segment consists of Cardiac Rhythm Management, Electrophysiology and Neuromodulation businesses. Its Cardiovascular segment consists of Interventional Cardiology and Peripheral Interventions businesses. Its product offerings include balloon catheters, rotational atherectomy systems, guide wires, guide catheters, embolic protection devices and diagnostic catheters used in percutaneous transluminal coronary angioplasty (PTCA) procedures.